A Proposed Brain-, Spine-, and Mental- Health Screening Methodology (NEUROSCREEN) for Healthcare Systems: Position of the Society for Brain Mapping and Therapeutics
Abstract
The COVID-19 pandemic has accelerated neurological, mental health disorders, and neurocognitive issues. However, there is a lack of inexpensive and efficient brain evaluation and screening systems. As a result, a considerable fraction of patients with neurocognitive or psychobehavioral predicaments either do not get timely diagnosed or fail to receive personalized treatment plans. This is especially true in the elderly populations, wherein only 16% of seniors say they receive regular cognitive evaluations. Therefore, there is a great need for development of an optimized clinical brain screening workflow methodology like what is already in existence for prostate and breast exams. Such a methodology should be designed to facilitate objective early detection and cost-effective treatment of such disorders. In this paper we have reviewed the existing clinical protocols, recent technological advances and suggested reliable clinical workflows for brain screening. Such protocols range from questionnaires and smartphone apps to multi-modality brain mapping and advanced imaging where applicable. To that end, the Society for Brain Mapping and Therapeutics (SBMT) proposes the Brain, Spine and Mental Health Screening (NEUROSCREEN) as a multi-faceted approach. Beside other assessment tools, NEUROSCREEN employs smartphone guided cognitive assessments and quantitative electroencephalography (qEEG) as well as potential genetic testing for cognitive decline risk as inexpensive and effective screening tools to facilitate objective diagnosis, monitor disease progression, and guide personalized treatment interventions. Operationalizing NEUROSCREEN is expected to result in reduced healthcare costs and improving quality of life at national and later, global scales.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Mar 08, 2022
- Source ID
- 10.3233/jad-215240
Entities
People
- Aaron Filler
- Alena Mohd-yusof
- Alero Mayuku-dore
- Ambooj Tiwari
- Antal Berenyi
- Babak Kateb
- Chris Wheeler
- Dahabada Lopes
- Daniel Sipple
- David Hagedorn
- Dawn S. Eliashiv
- Deborah Zelinsky
- Deepak Chopra
- Eric Braverman
- Ernesto Palmero Soler
- Gilberto E. Sanchez
- J. Wesson Ashford
- Jason Cormier
- Joe F. Bolanos
- John Fiallos
- John S. Yu
- Justin Dye
- Ken Green
- Kenneth Blum
- Kevin Morris
- Leslie S. Prichep
- Manjari Tripathi
- Maria Lobo
- Marinela Gombosev
- Mark Liker
- Martin Mortazavi
- Melody Sadri
- Michael J. Roy
- Mike Chen
- Milena Asiryan
- Mohammad Nami
- Morgan Ingemanson
- Namath Hussain
- Nasser Kashou
- Nevzat Tarhan
- Nicholas Peatfield
- Robert Hariri
- Robert Thatcher
- Solventa Krakauskaite
- Steven C. Cramer
- Teshia Bustos
- Vicky Yamamoto
- Walter G. Besio
- Xiaofan Guo
- Yousef Salimpour
Organizations
- Brain Mapping Foundation
- Cedars-Sinai Medical Center
- Children's Hospital Los Angeles
- City of Hope National Medical Center
- Grossman School of Medicine
- Johns Hopkins University
- Keck School of Medicine of USC
- Loma Linda University
- New York University
- PATH Foundation
- Shiraz University of Medical Sciences
- Society for Brain Mapping and Therapeutics
- Stanford University
- The Chopra Foundation
- Uniformed Services University of the Health Sciences
- University of California, Los Angeles
- University of Rhode Island
- Weill Cornell Medical Center
- Üsküdar University